ALT vs MS · rev $20.0K vs P/E 20, $344.27B cap
Altimmune Inc (ALT) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
MS does not have a complete income-statement cache yet.
ALT currently screens at market cap $527.0M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the ALT and MS stock pages for the full models.
Not investment advice.